MXCT logo

MXCT
MaxCyte Inc

447
Mkt Cap
$87.12M
Volume
360,786.00
52W High
$2.96
52W Low
$0.6434
PE Ratio
-1.94
MXCT Fundamentals
Price
$0.833
Prev Close
$0.8153
Open
$0.82
50D MA
$0.7678
Beta
1.38
Avg. Volume
1.04M
EPS (Annual)
-$0.4194
P/B
0.51
Rev/Employee
$362,923.08
$79.86
Loading...
Loading...
News
all
press releases
MaxCyte (NASDAQ:MXCT) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded shares of MaxCyte from a "sell" rating to a "hold" rating in a research note on Tuesday...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Brokerages
MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two...
MarketBeat·21d ago
News Placeholder
Craig Hallum Issues Pessimistic Forecast for MaxCyte (NASDAQ:MXCT) Stock Price
Craig Hallum reduced their target price on MaxCyte from $7.00 to $5.00 and set a "buy" rating for the company in a research note on Wednesday...
MarketBeat·23d ago
News Placeholder
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·24d ago
News Placeholder
MaxCyte Q4 Earnings Call Highlights
MaxCyte (NASDAQ:MXCT) executives told investors the company made meaningful progress in 2025 despite a difficult operating environment, highlighting continued strategic platform license (SPL...
MarketBeat·24d ago
News Placeholder
MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of +25.00% and -17.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·24d ago
News Placeholder
MaxCyte (NASDAQ:MXCT) Issues Earnings Results
MaxCyte (NASDAQ:MXCT - Get Free Report) released its earnings results on Tuesday. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by...
MarketBeat·24d ago
News Placeholder
MaxCyte (NASDAQ:MXCT) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen lowered MaxCyte from a "hold" rating to a "sell" rating in a research report on Monday...
MarketBeat·26d ago
News Placeholder
MaxCyte, Inc. $MXCT Shares Bought by Mirabella Financial Services LLP
Mirabella Financial Services LLP grew its holdings in MaxCyte, Inc. (NASDAQ:MXCT - Free Report) by 24.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,200,000 shares of the company's stock aft...
MarketBeat·29d ago
News Placeholder
Mirabella Financial Services LLP Purchases 1,600,000 Shares of MaxCyte, Inc. $MXCT
Mirabella Financial Services LLP lifted its holdings in MaxCyte, Inc. (NASDAQ:MXCT - Free Report) by 24.2% during the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·1mo ago
<
1
2
...
>

Latest MXCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.